NCT06419010View on ClinicalTrials.gov

Leukocyte- and Platelet-Rich Fibrin in the Surgical Treatment of Medication-related Osteonecrosis of the Jaw

NANot yet recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

May 31, 2024

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions
Osteonecrosis of the Jaw
Interventions
PROCEDURE

Surgery with the use of L-PRF

The study protocol is the same as the standard surgery one but with additional use of L-PRF membranes

PROCEDURE

Standard surgery

The standard surgical treatment, taking place in the operating room under general anesthesia

Trial Locations (7)

31000

University Hospital, Toulouse

75013

University Hospital Pitié-Salpêtrière, Paris

Unknown

University Hospital - Centre François-Xavier Michelet, Bordeaux

University Hospital - Groupe hospitalier Pellegrin, Bordeaux

University Hospital, Limoges

University Hospital Gui de CHAULIAC, Montpellier

University Hospital, Toulouse

All Listed Sponsors
lead

University Hospital, Toulouse

OTHER

NCT06419010 - Leukocyte- and Platelet-Rich Fibrin in the Surgical Treatment of Medication-related Osteonecrosis of the Jaw | Biotech Hunter | Biotech Hunter